Jim Cramer’s Latest Lightning Round: 7 Stocks in Focus

4. Illumina, Inc. (NASDAQ:ILMN)

Number of Hedge Fund Holders: 61

Cramer mentioned Illumina, Inc. (NASDAQ:ILMN) during the episode, and here’s what Mad Money’s host had to say:

“Well, Illumina is a challenged company and I don’t really care for it. I do prefer Thermo Fisher, TMO, they do a better job. And I, we own Danaher for the Charitable Trust and here we’re betting on a management change because right now, that company’s run much more poorly than it should be.”

Illumina (NASDAQ:ILMN) specializes in genetic and genomic analysis by offering sequencing and array-based solutions, including instruments, consumables, whole-genome sequencing kits, and targeted resequencing kits, along with various testing and support services. It is worth noting that in 2021 when Cramer was asked about the company, he stated:

“Look, Illumina is a fantastic company. I’m not just saying that because we know [Dr. Scott Gottlieb] is on the board. Illumina is a winner. They made a fantastic acquisition. They are gene sequencer parts. … I would buy the stock.”

Since his comment was aired in December 2021, Illumina (NASDAQ:ILMN) stock declined around 76%.